chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I tested positive for Covid-19 on March 23, 2023 I experienced sniffles, dry cough, I was prescribed Paxlovid for my symtoms.
Welt, 5" dia. Hive at sight of shot.  Body aches and fever
Felt tired at 8 p.m. went to bed early I woke at 11:30 p.m. with severe arm neck ear and face pain radiating from injection site I woke again at 3:39 a.m. with severe chills and then hot flash fever event. At that point I could not even lift my arm the whole left side from my injection site to the scalp with raw red and throbbing. Awoke at 5:30 a.m. to slightly swollen eyes and slightly swollen face. 6 a.m. severe diarrhea which lasted in several events through until 8 a.m.
Flu like symptoms, chills, left arm pain and bruising, right arm pain, fatigue, all in 24 hours after vaccine, all lasting 72 hours.  CoVid arm- large huge, hot to the touch, sore and bright red circle; began 7-10 days after vaccine administration and lasting 3 days before subsiding slowly.
I was 19 weeks pregnant at the start of my 2nd dose. My due date is September 8, 2021. The morning after getting the shot I began to have vaginal bleeding. I went to my OBGYN to have the baby checked. I was referred to a specialist for a level 2 ultrasound. Everything was found to be normal with the baby. The cause of the bleeding is still unknown by the timing aligns perfectly with my vaccine. The bleeding increased and has now began to slow.
The adverse event is that I received my first dose of the vaccine on July 24th and received a CDC COVID-19 Vaccination Record Card that stated moderna as my 1st dose of the covid vaccine but when I called the pharmacy to verify the information, because the follow up date was incorrect on the vaccine card, the pharmacy told me I had received the Pfizer vaccine as my first does not Moderna as stated on my vaccine card. When I received my follow up vaccine I showed the original card to the pharmacist and she kept it, refusing to return it to me. Then she had wrote the 1st dose for the pfizer vaccine and gave me a new card. I told her I took photos of the original card either way but she refused to return the card to me.
She felt lousy for 2-3 days but got better after that.; She had a fever of 102 F for a day, after which it dropped down to 100 F; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (She felt lousy for 2-3 days but got better after that.) and PYREXIA (She had a fever of 102 F for a day, after which it dropped down to 100 F) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 039K20A) for COVID-19 vaccination.     Patient did not had a COVID positive test or diagnosis. Patient had no other vaccines given within one month prior to Moderna COVID-19 vaccine.  Concurrent medical conditions included Drug allergy (Demerol) and Latex allergy (Latex sensitivity). Concomitant products included COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for an unknown indication.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 02-Feb-2021, the patient experienced FEELING ABNORMAL (She felt lousy for 2-3 days but got better after that.) and PYREXIA (She had a fever of 102 F for a day, after which it dropped down to 100 F). On 05-Feb-2021, FEELING ABNORMAL (She felt lousy for 2-3 days but got better after that.) and PYREXIA (She had a fever of 102 F for a day, after which it dropped down to 100 F) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102 (High) fever of 102°F for a day, after which it dropped down to 100°F. and 100 (High) fever of 102°F for a day, after which it dropped down to 100°F..         No treatment information was provided.   This case was linked to MOD-2022-539493 (Patient Link).
scar; Welt; This case was reported by a pharmacist via call center representative and described the occurrence of welts in a 63-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced welts and scar. On an unknown date, the outcome of the welts was recovered/resolved and the outcome of the scar was unknown.   It was unknown if the reporter considered the welts and scar to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported but it could be 62 or 63 years. The patient received a dose of Shingrix on an unknown arm. The patient was vaccinated about three months before the time of reporting and afterwards developed a welt near the injection site.  The welt resolved after a day, but the patient appeared to have a scar. The reporter consented to follow up.
Bell's palsy; This is a Literature report. This reporter reported 3 reports, this is the 3 of 3 reports. This case was split from master case 202101198829 for a patient taking Bnt162b2 and experienced Bell's palsy.This information was from FDA briefing document.    A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 2, single and first dose via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single, both for covid-19 immunisation.  The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced Bell's palsy. It was reported in the Food and Drug Administration briefings suggest risk of Bell's palsy is greatest within 1 month of a second vaccine dose. Of the Pfizer briefing notes "from dose 1 through 1 month after dose 2, there were three reports of Bell's palsy in the vaccine group and none in the placebo group". The outcome of the event was unknown.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101207187 Same article, different patients with same drug;US-PFIZER INC-202101207186 Same article, different patients with same drug
Shortly after the 2nd dose of the vaccine, this person went to an urgent care with a very swollen arm, she referred to it as 'Covid Arm'; She also indicated she was ill for about a month post the 2nd dose; This is a spontaneous report from a contactable consumer, Pfizer colleague. An adult non-pregnant female patient of unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history included 2 autoimmune disorders, unknown which ones. Prior to vaccination, the patient was not diagnosed with COVID-19. It was unknown whether the patient received any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On an unknown date, shortly after the second dose of the vaccine, the patient went to an urgent care with a very swollen arm. The patient referred to it as 'COVID arm'. The patient was ill for about a month post the second dose. The event swollen arm resulted in emergency room/department or urgent care. It was unknown whether therapeutic measures were taken as a result of the events. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the events swollen arm and illness were resolved on an unknown date.   The lot number for BNT162b2 was not provided and will be requested during follow up.
ID vaccination nurse reports bevel was not fully under skin causing vaccine to spray out in the air and on top of the pts' arm.  Patient educated/counseled on CDC recommendations.  Patient verbalized understanding and agreement/consent.  Dose repeated ID (pts request) without incident.
2/16/22 Diagnosed with rare bladder cancer 6 months after vaccination (Invasive, High-Grade Neuroendorcrine (Small Cell) Carcinoma). No family history of cancer and no other risk factors such as smoking or working in chemical industry.
Patient was given Moderna, was only eligible for Pfizer, no adverse reaction noted, no signs or symptoms of any allergic reaction
pt recv vax 12MAY97 1PM per mom;pt had immun @ clinic;430AM p/vax temp went up to 105, mom states pt had staring, spell & began to shake all over;pt transported to hosp ER;t102;poss sz again if fever goes up;sz JUN97;ear infect;
This spontaneous report as received from a pharmacist refers to a 64 year old male patient. The patient's medical history included dysphonia. On 07-SEP-2014 the patient was vaccinated with PNEUMOVAX 23 (Dose/Frequency: Unspecified, Therapy Route: Unspecified). Concomitant therapies included BOTOX. Approximately on 08-SEP-2014 (reported as 24 hours after the dose was given), the patient experienced severe pain at the injection site which prevented him from sleeping. The patient also experienced numbness which was unilateral from his neck, down his left arm. The patient had previous dose of PNEUMOVAX 23 approximately in 2012 (reported as 2 years ago). Approximately in 2012 (reported as about 2 years ago) the patient had pneumonia. In May 2014 (reported as May of this year), the patient had a cardiac stent placed. The pharmacist stated that the patient has been taking ibuprofen and using cold compresses to address the injection site pain but it has not brought him relief. The patient sought medical attention and no lab diagnostic tests were performed. The outcome of pneumonia and cardiac stent placed was unknown. The outcome of severe pain at the injection site which prevented him from sleeping and numbness which is unilateral from his neck, down his left arm was reported as not recovered. The causality of the events was not reported. No product quality complaint (PQC) was filed for PNEUMOVAX 23. Additional information has been requested.
Fever Tmax 104 F, mild induration of anterolateral thighs bilaterally, mild cellulitis appearance, tender to palpation.
No adverse reaction- incorrect vaccine given dose should have Been Covid-19 Pfizer BioNTech Bivalent for this patinets booster dose.
10/2/09 approx. 9:30 pm L side of face, below L eye down to L lip side felt numb. More intense on 10/3/09 now including L side of skull, from back  center of head to L ear, very strong numb sensation (not pain) tight numbness.
Mild rash with first dose of Pfizer-BioNTech COVID 19 vaccine.  Evaluated in ED for rash. Gave diphenhydramine 25 mg PO and observed for 1 hour. Patient felt comfortable discharging and returning if symptoms worsened.
This spontaneous report as received from a consumer (patient's mother) refers to a 3 year old patient. On an unknown date the patient was vaccinated with a dose of RECOMBIVAX HB (dose, route, lot# and expiration date were not provided). Mother of the patient reported that after her daughter received RECOMBIVAX HB "she has not been the same, she has become anti-social, shorter attention span, can't focus easily" (onset dates unknown). The patient complained of vaginal, stomach and anal pains (onset date unknown). There was a lot yeast in her vagina and she needed to be bathed multiple times a day. Mother has had to change the patient's diet. Patient sought medical attention. Nystatin was given for the treatment. Patient's mother was not really sure if the patient received RECOMBIVAX HB. The outcomes of all events were reported as not recovered/not resolved. Relatedness between the events and RECOMBIVAX HB was not provided. Additional information is not expected, because there are no contact details.
Moderns COVID-19 Vaccine EUA  Chills, Aching, Fatigue, Fever, Headache, Dizziness, Blurred vision
Received vaccine 11-28-16. This morning mom noted red rash over injection site and it was firm to touch. -Left deltoid with a 3x3 inch area of redness. Mildly warm to touch. ROM normal.
bloody nose; Lower back pain; Headache; This is a spontaneous report from a contactable Physician (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: Unknown), via intramuscular route of administration in right arm on an unspecified date as dose 2, single for COVID-19 immunisation at hospital. The patient medical history and concomitant medications were not reported. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: Unknown), via unknown route of administration on an unspecified date as dose 1, single for COVID-19 immunisation. The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient not had COVID-19. Since the vaccination, the patient had not been with COVID-19. The patient experienced bloody nose, lower back pain, headache on an unspecified date. The patient did not receive any treatment for the events. The outcome of events was reported as recovered on an unknown date.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Weak, dizzy, sleepy, body overall discomfort. Got worse over time. Slept 14 hours and stumbled around and just rested for that day. Next day woke with severe back pain like shingles probably feels. Suffered greatly. Heat on back helped reduce terrible pain. After about 60 hours from time of shot symptoms diminished mostly.
Swelling reported around mouth and eyes; Swelling reported around mouth and eyes; rash; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (Pfizer-BIONTECH COVID-19 vaccine), via an unspecified route of administration on 22Dec2020 16:30 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took doxycycline in 2019 and experienced swelling reported around mouth and eyes and rash. On an unspecified date in Dec2020, the patient experienced swelling reported around mouth and eyes and rash. The outcome of the events was unknown.  Information on the lot/Batch number has been requested.
a severe allergic reaction; broke out in a rash; This is a spontaneous report from a contactable other HCP (nurse) reporting for herself.  A female patient of an unspecified age received first dose of BNT162B2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced a severe allergic reaction and broke out in a rash on an unspecified date. Reporter stated that she got her first shot and the whole top of body broke out in a rash, should she get the second shot. It was all over the trunk of body. Reporter stated she got a paper here. It says Pfizer biontech covid 19 vaccine. She does know she has a paper and it said that if you have difficulty breathing, swelling of the face and throat or a bad rash all over body that its supposed to be a severe allergic reaction. Outcome of the events was unknown.  Information about lot/batch number requested.; Sender's Comments: Considering temporal relationship, the reported severe allergic reaction with rash were likely related to vaccination with BNT162B2.  The case will be reassessed should additional information become available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to agencies, as appropriate.
pt recv vax;2 hrs later was very unresponsive, very limp, hypotonic & hyporesponsive; re examined at 7pm same day exam nl;
This case was reported by a pharmacist via claims management company and described the occurrence of adverse event(s) in a subject of unspecified age and gender who was vaccinated with FLULAVAL TETRA (GlaxoSmithKline). On 25 January 2014 the subject received a dose of FLULAVAL (unknown details). In January 2014, within days of vaccination with FLULAVAL, the subject experienced adverse event(s). At the time of reporting the outcome of the event(s) was unspecified.
All of a sudden (Sat.)fell in a fog, couldn't get my mind to clear, then fell from chair.    After my son arrived and sat me up took my BP.  It was in the high 170s over high 90s.  it stayed that way until 5:30 finally started dropping.  I could talk, squeeze my hand, nothing else seemed wrong.  by Sunday BP was in the 146/88 range.  I reported it to my doctor on Monday.  Today (Tuesday) it was 136/80 more my normal range.  I could not think of anything different happening to me other than getting my Moderna BOOSTER on Thursday.
Patient received two vaccinations. SHINGRIX Lot # HG4P3 in left arm and PNEUMOVAX 23 in Right Arm. A few hours after receiving vaccine, patient's right arm began to ache/hurt severely and she began to feel weak. Husband called pharmacy to report she was on the couch feeling terrible.  Advised him to give her Acetaminophen and would call back to check on her later. Called patient's home the next day and husband reported that she felt so bad later in the evening that he took her to the ER. He felt she was also reacting to the Acetaminophen as she rarely takes any medication. She was examined at the ER and sent home. By the time of follow-up she was improving and able to use the arm a little. Spouse noted at that time that the affected arm was the side she had her mastectomy on. She was by then experiencing a lesser degree of soreness also in the left arm. Followed up with spouse a few days late and patient was doing well.
Immediately post vax, mother noted face to reddened - hives on face and back. No erythema around injection site. Benadryl 17.0 mg PO given at 16:15. Decreased facial and trunk redness. Sent home with script for Benadryl.
Acute onset left foot pain (5th metatarsal protuberance), lasted six days, resolved with ibuprofen, colchicine, Keflex.  Prompted urgent care clinic visit on 4/13/2021 where x-rays showed no abnormalities.  Diagnosed as probable gout flare (my first first diagnosis of gout, but second episode of this type of pain).
6 month old female had 3 minute episode of whole body trembling-06:30 AM 5/17/06-way post vaccines. No previous illness. No treatment.
This spontaneous report was received from a pharmacist refers to a 13 year old patient. On 20-JUN-2013, the patient was vaccinated with an adult dose (first dose) of VAQTA, (lot number, expiry date and route was not reported). Concomitant medications were not reported. No adverse effects were reported. Additional information is not expected.
hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     Concurrent medical conditions included Food allergy.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, the patient experienced URTICARIA (hives). At the time of the report, URTICARIA (hives) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication use was provided by the reporter.  The patient reported treatment of hives was with steroids on unknown start date.
Lipoma; This is a spontaneous report received from a contactable other hcp. A 36-years-old female patient received 1st dose of bnt162b2 (COMIRNATY,Batch/Lot Number: EL1283),via an unspecified route of administration, at the age of 36 years old,administered in Arm Left on 14Jan2021 09:00 as Dose 1,single for covid-19 immunization .Medical history included drug hypersensitivity from an unknown date and unknown if ongoing. Concomitant medications included sambucus nigra fruit (ELDERBERRY [SAMBUCUS NIGRA FRUIT]); calcium carbonate, ergocalciferol (CALCIUM AND VITAMIN D) taken for an unspecified indication, start and stop date were not reported.The patient experienced lipoma on 21Jan2021 07:00.The patient was not pregnant at the time of vaccination.The patient had not received any other vaccine within 4 weeks.The adverse event lipoma was noted 1 week post vaccination.The patient was not diagnosed with covid prior vaccination and not tested for covid post vaccination.This adverse event didn't result in patient visit to hospital and physician clinic.The outcome of the event was not recovered.  Follow-up (11May2021): Follow-up attempts completed. No further information expected.
Complaints of headache. Denied any nausea, respiratory involvement, or faintness. No SOB or difficulty breathing. LS clear on auscultation. HR regular. . BP 140/80 and client stated this is common for her with history of hypertension. Provided water and snack, observed for 30 minutes. Headache had lessened by end of observation.
Vaccine administration error - patient is a 17 year old and vaccine received EUA for 18 years of age and older.
Client received Dtap, MMR, Polio at 11am on 7/20/06. Developed fever of 102 seven hours later fever spiked to 105 despite Motrin x2. Fever then decreased to 99 but spiked again to 105 with stomach cramping lasting 1.5 hours. Woke the next morning without further similiar symptoms.
patient with hx of Guillan-barre syndrome after influenza vaccine 2 years ago with recurrent quadreplegia 3 weeks after receiving pfizer covid vaccine. patient does not remember exact date of vaccination and does not have lot number available.
This spontaneous report was received from a registered nurse refers to a patient of unknown age and gender. No medical history was reported. On an unspecified date approximately on April 2011 (reported as approximately 2 years ago), the patient was vaccinated with dose 2 of GARDASIL (lot #, expiry not reported), 0.5 ml, intramuscularly. No concomitant medications were reported. Additional information has been requested.
Dizziness, scratchy throat. At 1 hour, felt like throat was closing. Recurred over next two days intermittently. Tolerated second dose.
This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. Patient's medical history and concurrent conditions were not reported. On an unknown date, the patient was vaccinated with a dose of PNEUMOVAX 23 (lot # and expiry date not reported). Other co-suspect or concomitant medications were not reported. On an unknown date, the patient experienced mild reaction to PNEUMOVAX 23: redness, swelling, and warmth. The outcome of swelling, feeling hot and erythema was unknown. Additional information is not expected.
WIDESPREAD URTICARIA       ALSO WITH COUGHING AND DYSPNEA THE DAY BEFORE WHICH RESOLVED AFTER VENTOLIN USE X 1
Information has been received from a registered nurse (RN) concerning a 17 week old patient who on 19-MAR-2008 was vaccinated po with the first dose of ROTATEQ. The RN reported that there was no adverse event. A product quality complaint was not involved. Additional information has been requested.